Magnetar Financial LLC Raises Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Magnetar Financial LLC grew its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 19.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 708,732 shares of the medical device company's stock after acquiring an additional 117,720 shares during the period. Cooper Companies comprises 1.5% of Magnetar Financial LLC's investment portfolio, making the stock its 15th biggest holding. Magnetar Financial LLC owned approximately 0.36% of Cooper Companies worth $65,154,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Byrne Asset Management LLC purchased a new position in Cooper Companies during the 4th quarter valued at about $33,000. OFI Invest Asset Management purchased a new position in shares of Cooper Companies in the fourth quarter valued at approximately $34,000. Brown Brothers Harriman & Co. grew its holdings in shares of Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock valued at $46,000 after purchasing an additional 275 shares in the last quarter. West Financial Advisors LLC purchased a new stake in Cooper Companies during the 4th quarter worth approximately $49,000. Finally, Atala Financial Inc purchased a new stake in Cooper Companies during the 4th quarter worth approximately $51,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

NASDAQ COO traded up $2.36 during trading hours on Monday, hitting $84.07. 2,343,447 shares of the stock were exchanged, compared to its average volume of 1,287,611. The Cooper Companies, Inc. has a 12-month low of $77.05 and a 12-month high of $112.38. The stock has a 50-day moving average of $90.05 and a 200 day moving average of $98.04. The company has a market cap of $16.81 billion, a price-to-earnings ratio of 43.11, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Remove Ads

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on COO shares. Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Friday, December 6th. Robert W. Baird decreased their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Stifel Nicolaus dropped their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. StockNews.com downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.